- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07654504
Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) is a disease-specific patient-reported outcome measure developed to evaluate the impact of brachial plexus injury on daily life, functional status, and psychosocial well-being. There is currently no Turkish version of the IMBPIQ with established validity and reliability. Considering the increasing importance of culturally adapted patient-reported outcome measures, this study aims to translate the IMBPIQ into Turkish, perform its cultural adaptation, and evaluate the validity and reliability of the Turkish version for use in adults with brachial plexus birth palsy.
This study is designed as a methodological validity and reliability study. Written permission has been obtained from the original developers of the IMBPIQ for translation, cultural adaptation, and psychometric testing. The English version of the questionnaire will be translated into Turkish by independent translators. The translated versions will be reviewed by a committee, and a single Turkish version will be created based on consensus. This Turkish version will then be back-translated into English by a translator whose native language is English and who is proficient in both languages. The original version and the back-translated version will be compared in terms of semantic equivalence, linguistic appropriateness, and cultural adaptation, and the final Turkish version of the questionnaire will be established.
A pilot test will be conducted with 10 participants to evaluate the comprehensibility and applicability of the Turkish version of the questionnaire. Based on the feedback obtained from the pilot test, final revisions will be made before the main study. The main study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete a sociodemographic and clinical information form, the Turkish version of the IMBPIQ, the Disabilities of the Arm, Shoulder and Hand questionnaire, and the Short Form-36.
The IMBPIQ consists of 43 items and includes four main subdomains: symptoms, limitations, emotional status, and expected or achieved improvement after surgery or treatment. Raw scores obtained from the responses are converted into normalized standard scores ranging from 0 to 100. The disability domain score is calculated using the symptoms, limitations, and emotional status subdomains, with higher scores indicating greater disability and psychosocial impact. The improvement domain score reflects the expected or achieved improvement related to surgery or treatment, with higher scores indicating greater expected or perceived improvement.
The Disabilities of the Arm, Shoulder and Hand questionnaire will be used to evaluate upper extremity symptoms and functional disability. The Short Form-36 will be used to assess health-related quality of life. These measures will be used to examine the construct validity of the Turkish IMBPIQ through correlations with related patient-reported outcome measures.
Statistical analyses will be performed using IBM SPSS Statistics software. Descriptive statistics will be calculated to summarize participants' sociodemographic and clinical characteristics. Internal consistency reliability will be evaluated using Cronbach's alpha coefficient. Test-retest reliability will be examined by re-administering the Turkish IMBPIQ to 30 participants after a two-week interval, and agreement between the two assessments will be analyzed using the intraclass correlation coefficient. Construct validity will be assessed using Pearson or Spearman correlation analyses between the IMBPIQ scores and the scores obtained from the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The statistical significance level will be accepted as p < 0.05.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Fahri Dogukan Bozkurt, Physiotherapist, MSc Student
- Telefonnummer: +905392870087
- E-post: fahrib@biruni.edu.tr
Studera Kontakt Backup
- Namn: Zeynep Hosbay, Physiotherapist, Prof.
- Telefonnummer: +905055034279
- E-post: zhosbay@biruni.edu.tr
Studieorter
-
-
Istanbul
-
Istanbul, Istanbul, Turkiet (Türkiye), 34015
- Rekrytering
- Biruni University
-
Kontakt:
- Fahri Dogukan Bozkurt, Physiotherapist, MSc Student
- Telefonnummer: +905392870087
- E-post: fahrib@biruni.edu.tr
-
Kontakt:
- Zeynep Hosbay, Physiotherapist, Prof.
- Telefonnummer: +905055034279
- E-post: zhosbay@biruni.edu.tr
-
Huvudutredare:
- Zeynep Hosbay, Physiotherapist, Prof.
-
Underutredare:
- Fahri Dogukan Bozkurt, Physiotherapist, MSc Student
-
Underutredare:
- Gulsena Utku Umut, Physiotherapist, PhD
-
Underutredare:
- Busra Ulker Eksi, Physiotherapist, PhD
-
Underutredare:
- Hayri Omer Berkoz, MD, Assoc. Prof.
-
Underutredare:
- Atakan Aydin, MD, Prof.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Being 18 years of age or older.
- Having a diagnosis of brachial plexus birth palsy.
- Having the ability to read, write, speak, and understand Turkish.
- Agreeing to participate voluntarily in the study and signing the informed consent form.
Exclusion Criteria:
- Having a neurological disease.
- Having another orthopedic problem or a history of trauma in the affected upper extremity.
- Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions.
- Having a history of systemic disease requiring an acute attack or hospitalization within the last three months.
- Being pregnant or being in the postpartum period of less than 6 months.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Adults With Brachial Plexus Birth Palsy
Adults aged 18 years and older with a diagnosis of brachial plexus birth palsy who will complete the Turkish version of the Impact of Brachial Plexus Injury Questionnaire and related assessment tools.
|
Participants will complete the Turkish version of the Impact of Brachial Plexus Injury Questionnaire, the Disabilities of the Arm, Shoulder and Hand questionnaire, and the Short Form-36.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Validity and Reliability of the Turkish IMBPIQ
Tidsram: Baseline and after 1 week
|
The validity and reliability of the Turkish version of the Impact of Brachial Plexus Injury Questionnaire will be evaluated.
Reliability will be assessed using internal consistency and test-retest reliability analyses.
Validity will be assessed using construct validity analyses through correlations with related patient-reported outcome measures.
|
Baseline and after 1 week
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Upper Extremity Disability
Tidsram: Baseline
|
Upper extremity disability will be assessed using the Disabilities of the Arm, Shoulder and Hand questionnaire.
Higher scores indicate greater upper extremity disability.
|
Baseline
|
|
Health-Related Quality of Life
Tidsram: Baseline
|
Health-related quality of life will be assessed using the Short Form-36.
The scale includes subdomains related to physical and mental health, with higher scores indicating better health status.
|
Baseline
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Zeynep Hosbay, Physiotherapist, Prof., Biruni University
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- 2024-BİAEK/19-38
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .